Treatment of acute transverse myelitis and its early complications

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Acute transverse myelitis (ATM) has many potential etiologies, but a significant proportion of cases are categorized as idiopathic despite thorough evaluation. Clinical presentation of ATM typically includes some combination of motor weakness, sensory symptoms, and bowel and bladder dysfunction. Prompt recognition, even before a final etiologic diagnosis is reached, is critical to initiating early therapeutic intervention to reduce the harmful effects of inflammation. Acute therapeutic options for ATM include corticosteroids, plasma exchange, IV immunoglobulin, and chemotherapeutic agents such as cyclophosphamide. In some instances, combinations of these therapies are used. This article examines the therapeutic approach to ATM and its various acute clinical manifestations.

Original languageEnglish (US)
Pages (from-to)733-743
Number of pages11
JournalCONTINUUM Lifelong Learning in Neurology
Volume17
Issue number4
StatePublished - Aug 2011

Fingerprint

Transverse Myelitis
Plasma Exchange
Intravenous Immunoglobulins
Therapeutics
Cyclophosphamide
Adrenal Cortex Hormones
Urinary Bladder
Inflammation

ASJC Scopus subject areas

  • Clinical Neurology
  • Genetics(clinical)

Cite this

Treatment of acute transverse myelitis and its early complications. / Greenberg, Benjamin M.

In: CONTINUUM Lifelong Learning in Neurology, Vol. 17, No. 4, 08.2011, p. 733-743.

Research output: Contribution to journalArticle

@article{69854a6742e847c28b1b5a3cdbd472bf,
title = "Treatment of acute transverse myelitis and its early complications",
abstract = "Acute transverse myelitis (ATM) has many potential etiologies, but a significant proportion of cases are categorized as idiopathic despite thorough evaluation. Clinical presentation of ATM typically includes some combination of motor weakness, sensory symptoms, and bowel and bladder dysfunction. Prompt recognition, even before a final etiologic diagnosis is reached, is critical to initiating early therapeutic intervention to reduce the harmful effects of inflammation. Acute therapeutic options for ATM include corticosteroids, plasma exchange, IV immunoglobulin, and chemotherapeutic agents such as cyclophosphamide. In some instances, combinations of these therapies are used. This article examines the therapeutic approach to ATM and its various acute clinical manifestations.",
author = "Greenberg, {Benjamin M.}",
year = "2011",
month = "8",
language = "English (US)",
volume = "17",
pages = "733--743",
journal = "CONTINUUM Lifelong Learning in Neurology",
issn = "1080-2371",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Treatment of acute transverse myelitis and its early complications

AU - Greenberg, Benjamin M.

PY - 2011/8

Y1 - 2011/8

N2 - Acute transverse myelitis (ATM) has many potential etiologies, but a significant proportion of cases are categorized as idiopathic despite thorough evaluation. Clinical presentation of ATM typically includes some combination of motor weakness, sensory symptoms, and bowel and bladder dysfunction. Prompt recognition, even before a final etiologic diagnosis is reached, is critical to initiating early therapeutic intervention to reduce the harmful effects of inflammation. Acute therapeutic options for ATM include corticosteroids, plasma exchange, IV immunoglobulin, and chemotherapeutic agents such as cyclophosphamide. In some instances, combinations of these therapies are used. This article examines the therapeutic approach to ATM and its various acute clinical manifestations.

AB - Acute transverse myelitis (ATM) has many potential etiologies, but a significant proportion of cases are categorized as idiopathic despite thorough evaluation. Clinical presentation of ATM typically includes some combination of motor weakness, sensory symptoms, and bowel and bladder dysfunction. Prompt recognition, even before a final etiologic diagnosis is reached, is critical to initiating early therapeutic intervention to reduce the harmful effects of inflammation. Acute therapeutic options for ATM include corticosteroids, plasma exchange, IV immunoglobulin, and chemotherapeutic agents such as cyclophosphamide. In some instances, combinations of these therapies are used. This article examines the therapeutic approach to ATM and its various acute clinical manifestations.

UR - http://www.scopus.com/inward/record.url?scp=80053912143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053912143&partnerID=8YFLogxK

M3 - Article

C2 - 22810928

AN - SCOPUS:80053912143

VL - 17

SP - 733

EP - 743

JO - CONTINUUM Lifelong Learning in Neurology

JF - CONTINUUM Lifelong Learning in Neurology

SN - 1080-2371

IS - 4

ER -